Within this analysis, we did not find substantial changes, especially T cells in TME composition relating to the expression of MAVS (Figure S13), in contrast to what has been reported for solid tumors27 and consistent with our observation here, i.e., in B cell lymphomas, expression of MAVS positively correlated with ISG/NF-κB scores (Figures 3C–3F). The gene discussed is MAVS; the disease is B-cell non-Hodgkin lymphoma.